198 related articles for article (PubMed ID: 8347496)
21. Immunohistochemical analysis of p53 in colorectal cancer regarding clinicopathological correlation and prognostic significance.
Tomoda H; Kakeji Y
J Surg Oncol; 1995 Feb; 58(2):125-8. PubMed ID: 7844983
[TBL] [Abstract][Full Text] [Related]
22. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma.
Michelassi F; Ayala JJ; Balestracci T; Goldberg R; Chappell R; Block GE
Ann Surg; 1991 Jul; 214(1):11-8. PubMed ID: 2064465
[TBL] [Abstract][Full Text] [Related]
23. p53 nuclear protein overexpression in colorectal cancer: a dominant predictor of survival in patients with advanced hepatic metastases.
Belluco C; Guillem JG; Kemeny N; Huang Y; Klimstra D; Berger MF; Cohen AM
J Clin Oncol; 1996 Oct; 14(10):2696-701. PubMed ID: 8874329
[TBL] [Abstract][Full Text] [Related]
24. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience.
Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
Jpn J Clin Oncol; 2000 Jan; 30(1):12-6. PubMed ID: 10770562
[TBL] [Abstract][Full Text] [Related]
25. Lymph Node Micrometastasis Cannot Be Considered as Positive Lymph Node in Nonmetastatic Colorectal Cancer.
Hong KD; Um JW; Min BW; Ji WB; Choi JW; Kim YS
Am Surg; 2017 Feb; 83(2):127-133. PubMed ID: 28228198
[TBL] [Abstract][Full Text] [Related]
26. Macroscopic features at the deepest site of tumor penetration predicting liver metastases of colorectal cancer.
Inomata M; Ochiai A; Sugihara K; Moriya Y; Yamaguchi N; Adachi Y; Kitano S; Hirohashi S
Jpn J Clin Oncol; 1998 Feb; 28(2):123-8. PubMed ID: 9544828
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of ras p21 overexpression for patients with an advanced colorectal cancer.
Miyahara M; Saito T; Kaketani K; Sato K; Kuwahara A; Shimoda K; Kobayashi M
Dis Colon Rectum; 1991 Dec; 34(12):1097-102. PubMed ID: 1959459
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma.
Zhang Hong
Clin Cancer Res; 1999 Dec; 5(12):4126-32. PubMed ID: 10632350
[TBL] [Abstract][Full Text] [Related]
29. Colorectal cancer: Lahey Clinic experience, 1972-1976. An analysis of prognostic indicators.
de Leon ML; Schoetz DJ; Coller JA; Veidenheimer MC
Dis Colon Rectum; 1987 Apr; 30(4):237-42. PubMed ID: 3829870
[TBL] [Abstract][Full Text] [Related]
30. Cancer invasion to Auerbach's plexus is an important prognostic factor in patients with pT3-pT4 colorectal cancer.
Fujita S; Nakanisi Y; Taniguchi H; Yamamoto S; Akasu T; Moriya Y; Shimoda T
Dis Colon Rectum; 2007 Nov; 50(11):1860-6. PubMed ID: 17899273
[TBL] [Abstract][Full Text] [Related]
31. NM-23 H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer.
Lindmark G
Br J Cancer; 1996 Nov; 74(9):1413-8. PubMed ID: 8912537
[TBL] [Abstract][Full Text] [Related]
32. High expression of AT-rich interactive domain 3A (ARID3A) is associated with good prognosis in colorectal carcinoma.
Song M; Kim H; Kim WK; Hong SP; Lee C; Kim H
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S481-9. PubMed ID: 24366420
[TBL] [Abstract][Full Text] [Related]
33. DNA polymerase alpha positive-cell rate in colorectal cancer and its relationship to prognosis.
Yamaguchi A; Hirono Y; Fushida S; Kurosaka Y; Kanno M; Yonemura Y; Miyazaki I
Br J Cancer; 1992 Mar; 65(3):421-4. PubMed ID: 1558798
[TBL] [Abstract][Full Text] [Related]
34. p53 alterations are associated with improved prognosis in distal colonic carcinomas.
Soong R; Grieu F; Robbins P; Dix B; Chen D; Parsons R; House A; Iacopetta B
Clin Cancer Res; 1997 Aug; 3(8):1405-11. PubMed ID: 9815825
[TBL] [Abstract][Full Text] [Related]
35. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
Lopes A; Bezerra AL; Pinto CA; Serrano SV; de MellO CA; Villa LL
J Urol; 2002 Jul; 168(1):81-6. PubMed ID: 12050497
[TBL] [Abstract][Full Text] [Related]
36. Influence of primary site on metastatic distribution and survival in stage IV colorectal cancer.
Suthananthan AE; Bhandari M; Platell C
ANZ J Surg; 2018 May; 88(5):445-449. PubMed ID: 28512795
[TBL] [Abstract][Full Text] [Related]
37. Budding (sprouting) as a useful prognostic marker in colorectal mucinous carcinoma.
Okuyama T; Oya M; Yamaguchi M
Jpn J Clin Oncol; 2002 Oct; 32(10):412-6. PubMed ID: 12451038
[TBL] [Abstract][Full Text] [Related]
38. Metalloproteinase-1, metalloproteinase-7, and p53 immunoexpression and their correlation with clinicopathological prognostic factors in colorectal adenocarcinoma.
Nunes BL; Jucá MJ; Gomes EG; Menezes HL; Costa HO; Matos D; Saad SS
Int J Biol Markers; 2009; 24(3):156-64. PubMed ID: 19787626
[TBL] [Abstract][Full Text] [Related]
39. Increased p53 protein content of colorectal tumours correlates with poor survival.
Remvikos Y; Tominaga O; Hammel P; Laurent-Puig P; Salmon RJ; Dutrillaux B; Thomas G
Br J Cancer; 1992 Oct; 66(4):758-64. PubMed ID: 1419618
[TBL] [Abstract][Full Text] [Related]
40. [Did the stage of diagnosis and the surgical management of colonic cancers change over the last ten years? Apropos of 303 patients].
Sales JP; Parc R
Ann Chir; 1994; 48(7):591-5. PubMed ID: 7864533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
